Recent innovations in topical delivery for management of rheumatoid arthritis: A focus on combination drug delivery
Authors:
- 27 June 2024
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (8) , 104071
Abstract
No abstract availableKeywords
Funding Information
- Birla Institute of Technology and Science, Pilani
This publication has 81 references indexed in Scilit:
- Comparison of individual and combination treatments with naproxen, prednisolone and hydroxychloroquine to treat Complete Freund’s Adjuvant induced arthritisInflammopharmacology, 2021
- Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritisClinical Rheumatology, 2020
- Ex vivo assessment of in vivo DC-targeted antibodies in pre-clinical models2019
- Natural product drug delivery: A special challenge?2019
- Diagnosis and Management of Rheumatoid ArthritisJAMA, 2018
- Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical InvestigationsPharmaceutical Research, 2018
- Flavonoid quercetin–methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritisInflammopharmacology, 2018
- Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical TechnologyDrugs, 2015
- Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trialArthritis & Rheumatism, 2004
- Mass transport Phenomena and Models: Theoretical ConceptsJournal of Pharmaceutical Sciences, 1974